.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
QuintilesIMS
Baxter
Covington
Argus Health
Farmers Insurance
Cipla
AstraZeneca
Novartis

Generated: June 27, 2017

DrugPatentWatch Database Preview

LOPROX Drug Profile

« Back to Dashboard

Which patents cover Loprox, and what generic Loprox alternatives are available?

Loprox is a drug marketed by Cnty Line Pharms, Medimetriks Pharms, and Medicis. and is included in four NDAs. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has eighty-two patent family members in thirty-four countries.

The generic ingredient in LOPROX is ciclopirox. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.

Summary for Tradename: LOPROX

Patents:4
Applicants:3
NDAs:4
Suppliers / Packagers: see list4
Bulk Api Vendors: see list54
Patent Applications: see list2,905
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LOPROX at DailyMed

Pharmacology for Tradename: LOPROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms
LOPROX
ciclopirox
GEL;TOPICAL020519-001Jul 21, 1997ABRXYesYes7,018,656► SubscribeY ► Subscribe
Medimetriks Pharms
LOPROX
ciclopirox
CREAM;TOPICAL018748-001Dec 30, 1982ABRXYesYes► Subscribe► Subscribe
Cnty Line Pharms
LOPROX
ciclopirox
GEL;TOPICAL020519-001Jul 21, 1997ABRXYesYes7,026,337► Subscribe ► Subscribe
Medimetriks Pharms
LOPROX
ciclopirox
SUSPENSION;TOPICAL019824-001Dec 30, 1988ABRXYesYes► Subscribe► Subscribe
Medicis
LOPROX
ciclopirox
SHAMPOO;TOPICAL021159-001Feb 28, 2003ATRXYesYes7,981,909► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LOPROX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medimetriks Pharms
LOPROX
ciclopirox
CREAM;TOPICAL018748-001Dec 30, 19823,883,545► Subscribe
Cnty Line Pharms
LOPROX
ciclopirox
GEL;TOPICAL020519-001Jul 21, 19977,026,337► Subscribe
Medimetriks Pharms
LOPROX
ciclopirox
SUSPENSION;TOPICAL019824-001Dec 30, 19883,883,545► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: LOPROX

Drugname Dosage Strength RLD Submissiondate
ciclopiroxGel0.77%Loprox5/10/2006

Premature patent expiration for: LOPROX

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
► Subscribe
LOPROX
► Subscribe

International Patent Family for Tradename: LOPROX

Country Document Number Estimated Expiration
Turkey9900723► Subscribe
Slovenia928183► Subscribe
Bulgaria103260► Subscribe
Czech Republic9901073► Subscribe
Brazil9711559► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Moodys
Novartis
Farmers Insurance
Cantor Fitzgerald
Colorcon
Healthtrust
Baxter
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot